Table 1.

Characteristics of patients

	Flutamide group (n = 11)	Bicalutamide group (n = 11)	P
Age (median, years)	79 (71–86)	79 (67–82)	0.84†
PSA (median, ng/mL)	12.4 (4.7–17.6)	10.4 (3.8–38.6)	0.69†
Testosterone (median, ng/mL)	4.7 (2.0–9.4)	4.5 (2.8–7.7)	0.90†
DHEA (median, ng/mL)	59 (18–167)	73 (36–230)	0.09†
Angiostenegione (median, ng/mL)	1.2 (0.6–1.9)	1.5 (0.9–3.0)	0.11†
Gleason score
6	2	3	0.91‡
7	9	8
8–10	0	0
Clinical T stage
T1	5	6	0.62‡
T2	5	5
T3	1	0
T4	0	0

^† Mann–Whitney U test; ^‡ chi-square test